Haploidentical hematopoietic cell transplantation using in vitro T cell depleted grafts as salvage therapy in patients with disease relapse after prior allogeneic transplantation. (Q40313702)

From Wikidata

Jump to navigation Jump to search

scientific article published on 28 February 2017

Language	Label	Description	Also known as
English	Haploidentical hematopoietic cell transplantation using in vitro T cell depleted grafts as salvage therapy in patients with disease relapse after prior allogeneic transplantation.	scientific article published on 28 February 2017

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28247058 AND SRC:MED&resulttype=core&format=json

4 April 2020

Haploidentical hematopoietic cell transplantation using in vitro T cell depleted grafts as salvage therapy in patients with disease relapse after prior allogeneic transplantation (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28247058 AND SRC:MED&resulttype=core&format=json

4 April 2020

Markus W. Löffler

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28247058 AND SRC:MED&resulttype=core&format=json

4 April 2020

author name string

Sebastian P Haen

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28247058 AND SRC:MED&resulttype=core&format=json

4 April 2020

Christiane Groh

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28247058 AND SRC:MED&resulttype=core&format=json

4 April 2020

Michael Schumm

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28247058 AND SRC:MED&resulttype=core&format=json

4 April 2020

Linus Backert

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28247058 AND SRC:MED&resulttype=core&format=json

4 April 2020

Birgit Federmann

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28247058 AND SRC:MED&resulttype=core&format=json

4 April 2020

Christoph Faul

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28247058 AND SRC:MED&resulttype=core&format=json

4 April 2020

Daniela Dörfel

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28247058 AND SRC:MED&resulttype=core&format=json

4 April 2020

Wichard Vogel

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28247058 AND SRC:MED&resulttype=core&format=json

4 April 2020

Rupert Handgretinger

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28247058 AND SRC:MED&resulttype=core&format=json

4 April 2020

Lothar Kanz

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28247058 AND SRC:MED&resulttype=core&format=json

4 April 2020

Wolfgang A Bethge

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28247058 AND SRC:MED&resulttype=core&format=json

4 April 2020

publication date

28 February 2017

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28247058 AND SRC:MED&resulttype=core&format=json

4 April 2020

Annals of Hematology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28247058 AND SRC:MED&resulttype=core&format=json

4 April 2020

96

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28247058 AND SRC:MED&resulttype=core&format=json

4 April 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28247058 AND SRC:MED&resulttype=core&format=json

4 April 2020

817-827

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28247058 AND SRC:MED&resulttype=core&format=json

4 April 2020

NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantatio

1 reference

https://api.crossref.org/works/10.1007/S00277-017-2941-X

21 January 2018

Second hematopoietic stem cell transplantation in myeloid malignancies

1 reference

https://api.crossref.org/works/10.1007/S00277-017-2941-X

21 January 2018

Second allograft for hematologic relapse of acute leukemia after first allogeneic stem-cell transplantation from related and unrelated donors: the role of donor change

1 reference

https://api.crossref.org/works/10.1007/S00277-017-2941-X

21 January 2018

Clinical options after failure of allogeneic hematopoietic stem cell transplantation in patients with hematologic malignancies

1 reference

https://api.crossref.org/works/10.1007/S00277-017-2941-X

21 January 2018

Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse After Hematopoietic Stem Cell Transplantation: part III. Prevention and treatment of relapse after allogeneic transpl

1 reference

https://api.crossref.org/works/10.1007/S00277-017-2941-X

21 January 2018

Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: a phase II study

1 reference

https://api.crossref.org/works/10.1007/S00277-017-2941-X

21 January 2018

Modern approaches to HLA-haploidentical blood or marrow transplantation

1 reference

https://api.crossref.org/works/10.1007/S00277-017-2941-X

21 January 2018

Effects of priming with recombinant human granulocyte colony-stimulating factor on conditioning regimen for high-risk acute myeloid leukemia patients undergoing human leukocyte antigen-haploidentical hematopoietic stem cell transplantation: a multic

1 reference

https://api.crossref.org/works/10.1007/S00277-017-2941-X

21 January 2018

Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT

1 reference

https://api.crossref.org/works/10.1007/S00277-017-2941-X

21 January 2018

Prediction of non-relapse mortality in recipients of reduced intensity conditioning allogeneic stem cell transplantation with AML in first complete remission.

1 reference

https://api.crossref.org/works/10.1007/S00277-017-2941-X

21 January 2018

A disease risk index for patients undergoing allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1007/S00277-017-2941-X

21 January 2018

Defining the intensity of conditioning regimens: working definitions

1 reference

https://api.crossref.org/works/10.1007/S00277-017-2941-X

21 January 2018

Chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1007/S00277-017-2941-X

21 January 2018

Poor graft function can be durably and safely improved by CD34 -selected stem cell boosts after allogeneic unrelated matched or mismatched hematopoietic cell transplantation.

1 reference

https://api.crossref.org/works/10.1007/S00277-017-2941-X

21 January 2018

Treatment of relapse after allogeneic bone marrow transplantation with reduced intensity conditioning (FLAG /- Ida) and second allogeneic stem cell transplant.

1 reference

https://api.crossref.org/works/10.1007/S00277-017-2941-X

21 January 2018

Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant

1 reference

https://api.crossref.org/works/10.1007/S00277-017-2941-X

21 January 2018

Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse of haematological malignancy after an initial allogeneic transplant.

1 reference

https://api.crossref.org/works/10.1007/S00277-017-2941-X

21 January 2018

Second haematopoietic SCT using HLA-haploidentical donors in patients with relapse of acute leukaemia after a first allogeneic transplantation

1 reference

https://api.crossref.org/works/10.1007/S00277-017-2941-X

21 January 2018

Outcomes of patients with AML and MDS who relapse or progress after reduced intensity allogeneic hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1007/S00277-017-2941-X

21 January 2018

Identifiers

10.1007/S00277-017-2941-X

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28247058 AND SRC:MED&resulttype=core&format=json

4 April 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28247058 AND SRC:MED&resulttype=core&format=json

4 April 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40313702&oldid=1488384890"